US Dementia Diagnoses Projected to Hit One Million Annually by 2060

The United States healthcare market faces a structural imbalance as the patient population expands while the provider workforce contracts and federal funding shrinks. New projections indicate that the annual number of dementia diagnoses will double within three decades, creating a sustained demand for care services that current infrastructure is not built to handle.

A 2024 study published in JAMA projects that annual US dementia diagnoses will rise from 514,000 in 2020 to 1 million by 2060. A related 2026 study in JAMA Neurology places global annual cases at 24.7 million by 2050, up from 11.4 million in 2023. Jordan Weiss, an assistant professor at the Optimal Aging Institute at NYU Langone, attributes the growth to increased life expectancy and the expansion of the Hispanic population, which nearly doubled between 2000 and 2024. The Alzheimer's Association notes that Hispanic individuals are 1.5 times as likely as white individuals to develop the condition.

The labor supply for these patients is already strained. A 2024 report from the American Health Care Association found that almost all nursing facilities reported difficulty recruiting staff, with two-thirds citing a lack of qualified candidates as the primary barrier. About half of these facilities limited new admissions. The Center for American Projects estimates that demand for nursing assistants will rise by 48% and demand for home health aides by 42% between 2020 and 2035. Despite this, the Bureau of Labor Statistics reported median wages of under $19 an hour for nursing assistants and $17 an hour for home health aides in May 2025. Regina Shih, a professor of epidemiology at Emory University, stated that retention rates are low because the work is difficult and cannot be replaced by artificial intelligence.

Specialist availability is also declining. The number of geriatricians in the US dropped from 10,270 in 2000 to 7,413 in 2022. Geriatrics is among the lowest paid medical specialties, a factor Weiss cited in the shortage. State-level financial incentives are attempting to bridge the gap. A KFF survey found that almost half of states offered incentive payments in 2025 to recruit or retain Medicaid home care workers. South Carolina established a loan forgiveness program for physicians completing geriatrics or geriatric psychiatry fellowships who practice in the state for at least five years.

Federal policy changes add financial pressure. The One Big Beautiful Bill Act, passed in 2025, includes nearly $1 trillion in Medicaid cuts over ten years. KFF reports that Medicaid funds more than half of US long-term care spending. Pharmaceutical options exist but come with costs. The FDA has approved two drugs, Kisunla and Leqembi, that modestly slow cognitive decline in some early Alzheimer's patients. Julie Zissimopoulos, a University of Southern California professor, noted that while these advances may improve lives, they will be costly for the healthcare system.

Weiss advised against waiting for a cure, emphasizing that better cardiovascular health and physical activity can lower risk. He described the current moment as an opportunity to build a system capable of delivering the care people already need.